Copyright
©The Author(s) 2020.
World J Diabetes. Dec 15, 2020; 11(12): 644-653
Published online Dec 15, 2020. doi: 10.4239/wjd.v11.i12.644
Published online Dec 15, 2020. doi: 10.4239/wjd.v11.i12.644
Univariate analysis | Multivariate analysis | |||||
ORs | 95%CI | P value | ORs | 95%CI | P value | |
Age (> 65 vs ≤ 65) | 1.29 | (0.39, 4.67) | 0.686 | |||
Sex (female vs male) | 1.48 | (0.48, 4.65) | 0.494 | |||
Diabetes | 7.13 | (2.03, 27.32) | 0.003 | 6.29 | (1.48, 31.34) | 0.016 |
Hypertension | 3.41 | (1.08, 11.35) | 0.039 | 1.63 | (0.38, 6.87) | 0.504 |
Heart diseases | 4.21 | (0.83, 23.79) | 0.083 | 2.94 | (0.42, 21.78) | 0.271 |
Hepatic dysfunction | 7.69 | (2.27, 33.33) | 0.002 | 5.88 | (1.45, 33.33) | 0.018 |
Mild-nonelung involvement | 0.37 | (0.11, 1.18) | 0.093 | 0.41 | (0.09, 1.78) | 0.239 |
- Citation: Xu M, Yang W, Huang T, Zhou J. Diabetic patients with COVID-19 need more attention and better glycemic control. World J Diabetes 2020; 11(12): 644-653
- URL: https://www.wjgnet.com/1948-9358/full/v11/i12/644.htm
- DOI: https://dx.doi.org/10.4239/wjd.v11.i12.644